Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Vaccination status among COVID-19 patients and duration of Polymerase Chain Reaction test positivity: evaluation of immunization schedule and type of vaccine.

  • Authors : Guerriero P; Department of Life, Health & Environmental Sciences, University of L'Aquila, Italy.; Cipollone C

Subjects: COVID-19*/COVID-19*/COVID-19*/diagnosis ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

  • Source: Annali di igiene : medicina preventiva e di comunita [Ann Ig] 2024 May-Jun; Vol. 36 (3), pp. 327-334. Date of Electronic Publication: 2024 Feb 22.Publisher: Societa Editrice Universo Country of Publication: Italy NLM ID: 9002865 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A prospective observational cohort study of covid-19 epidemiology and vaccine seroconversion in South Western Sydney, Australia, during the 2021-2022 pandemic period.

  • Authors : Potter D; University of Western Sydney, Sydney, NSW, Australia. .; University of New South Wales, Sydney, NSW, Australia. .

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

  • Source: BMC nephrology [BMC Nephrol] 2024 Apr 12; Vol. 25 (1), pp. 131. Date of Electronic Publication: 2024 Apr 12.Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369

Record details

×
Academic Journal

Prevalence of neutralizing antibodies against SARS-CoV-2 using a rapid serological test in health workers of a Spanish Department of Health in Alicante (Spain) before the booster dose of the vaccine.

  • Authors : Montagud AC; Laboratorio de Inmunología, Plataforma Oncológica, Hospital QuironSalud Torrevieja. Torrevieja, Alicante, Spain.; Llenas-García J

Subjects: COVID-19*/COVID-19*/COVID-19*/diagnosis ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Revista clinica espanola [Rev Clin Esp (Barc)] 2024 Apr; Vol. 224 (4), pp. 197-203. Date of Electronic Publication: 2024 Feb 27.Publisher: Elsevier España Country of Publication: Spain NLM ID: 101632437 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Deglycosylated RBD produced in Pichia pastoris as a low-cost sera COVID-19 diagnosis tool and a vaccine candidate.

Subjects: COVID-19*/COVID-19*/COVID-19*/diagnosis ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*/Vaccines*/Vaccines*/metabolism Komagataella pastoris

  • Source: Glycobiology [Glycobiology] 2024 Mar 19; Vol. 34 (1).Publisher: IRL Press at Oxford University Press Country of Publication: England NLM ID: 9104124 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Development of a potent recombinant scFv antibody against the SARS-CoV-2 by in-depth bioinformatics study: Paving the way for vaccine/diagnostics development.

  • Authors : Yaghoobizadeh F; Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Khouzestan, 6135783151, Iran. Electronic address: .; Roayaei Ardakani M

Subjects: Single-Chain Antibodies*/Single-Chain Antibodies*/Single-Chain Antibodies*/chemistry ; COVID-19* ; Vaccines*SARS-CoV-2 variants

  • Source: Computers in biology and medicine [Comput Biol Med] 2024 Mar; Vol. 170, pp. 108091. Date of Electronic Publication: 2024 Jan 28.Publisher: Elsevier Country of Publication: United States NLM ID: 1250250 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effectiveness of Vaccines and Antiviral Drugs in Preventing Severe and Fatal COVID-19, Hong Kong.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Humans

  • Source: Emerging infectious diseases [Emerg Infect Dis] 2024 Jan; Vol. 30 (1), pp. 70-78. Date of Electronic Publication: 2023 Dec 01.Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155

Record details

×
Academic Journal

Willingness to vaccinate among adults, and factors associated with vaccine acceptance of COVID-19 vaccines in a nationwide study in Poland between March 2021 and April 2022.

  • Authors : Kotronia E; Department of Epidemiology of Infectious Diseases and Surveillance, National Institute of Public Health - National Institute of Hygiene - National Research Institute, Warsaw, Poland.; ECDC Fellowship Programme, Field Epidemiology Path (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Adult

  • Source: Frontiers in public health [Front Public Health] 2023 Dec 04; Vol. 11, pp. 1235585. Date of Electronic Publication: 2023 Dec 04 (Print Publication: 2023).Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Adult

  • Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Nov; Vol. 23 (11), pp. 1235-1243. Date of Electronic Publication: 2023 Jul 12.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

COVID-19 Incidence Proportion as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine Type.

Subjects: COVID-19*/COVID-19*/COVID-19*/diagnosis ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Viruses [Viruses] 2023 Oct 30; Vol. 15 (11). Date of Electronic Publication: 2023 Oct 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

×
Academic Journal

When to be vaccinated? What to consider? Modelling decision-making and time preference for COVID-19 vaccine through a conjoint experiment.

  • Authors : Yue PHR; University College London, United Kingdom.; Lau HPB

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Drug-Related Side Effects and Adverse Reactions* ; Vaccines*

  • Source: Vaccine [Vaccine] 2023 Oct 06; Vol. 41 (42), pp. 6300-6308. Date of Electronic Publication: 2023 Sep 09.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  270 results for ""COVID-19 Testing""